US Stocks
/
Sutro Biopharma, Inc. Share Price
Sutro Biopharma, Inc. Share Price

Sutro Biopharma, Inc. Share Price

NASDAQ: STRO | Micro Cap
$14.69
-$0.72 (-4.7%) Last updated on 09 Oct, 2026 | 22:13 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Sutro Biopharma, Inc. Stock Performance

Open
$14.89
Prev. Close
$15.41
Circuit Range
N/A
Day Range
$14.74 - $14.89
Year Range
$0.72 - $42.38
Volume
3,702
Average Traded
$14.85

Sutro Biopharma, Inc. Share Price Today

As of 9 October 2026, Sutro Biopharma, Inc.'s share price is $14.69. The stock opened at $14.89, compared to its previous close of $15.41. During today's trading session, Sutro Biopharma, Inc.'s share price traded between $14.74 and $14.89, with an average price of $14.82. Over the past 52 weeks, the stock has recorded a high of $42.38 and a low of $0.72. In terms of performance, Sutro Biopharma, Inc.'s share price has declined by 60.02% over the last six months and is up 1222.97% on a year-on-year basis.

Sutro Biopharma, Inc. Share Price Chart

$14.74$14.89
L
Show Current Price
H

Sutro Biopharma, Inc. Stock Fundamentals & Key Indicators

Market Cap
$124.79M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-10.89
Revenue (TTM)
$102.48B
Return On Equity (TTM)
174.84%
Profit Margin
-186.47%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
32.24%

Sutro Biopharma, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$9.69$11.65$14.52$9.84
Net Profit-$56.86-$46.76-$38.48-$38.53
Net Profit Margin-586.79%-401.37%-265.01%-391.57%
Income ChangeN/A17.76%17.71%-0.13%

Sutro Biopharma, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$67.77$153.73$62.04$102.48
Net Profit-$119.20-$106.79-$227.46-$191.09
Net Profit Margin-175.89%-69.47%-366.63%-186.47%
Income ChangeN/A10.41%-113.00%15.99%

About Sutro Biopharma, Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Sutro Biopharma, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$15.99
$14.74
-9.32%
Sep 2026
$20.29
$16.26
-24.16%
Aug 2026
$23.35
$21.44
-11.29%
Jul 2026
$32.76
$24.17
-27.30%
Jun 2026
$28.31
$33.24
+14.82%
May 2026
$37.12
$28.95
-21.18%
Apr 2026
$25.53
$36.73
+48.01%
Mar 2026
$19.69
$24.82
+20.25%
Feb 2026
$14.76
$20.64
+40.41%
Jan 2026
$11.44
$14.70
+28.22%
Dec 2025
$0.85
$11.46
+1,153.01%
Nov 2025
$1.06
$0.92
-17.57%

STRO Share Price FAQs

What is Sutro Biopharma, Inc. share price today?

chevron-up
Sutro Biopharma, Inc. share price today is $14.69 as on October 9, 2026 at 10:13 pm IST.

What is the 52 week high and 52 week low of Sutro Biopharma, Inc. stock?

chevron-up
The 52 week high of Sutro Biopharma, Inc. stock is $42.38, while the 52 week low is $0.72 as of 9 Oct '26.

What is STRO's market capitalisation today?

chevron-up
STRO market capitalisation is $124.79M as of October 9, 2026, at 10:15 pm IST.

What is STRO's net income for the last quarter?

chevron-up
STRO's net income for the last quarter is -38.53B USD.

What is the 5 year returns of STRO?

chevron-up
The 5 year returns of STRO is -27.16% as on 9 Oct '26.

What is the high & low stock price of STRO today?

chevron-up
STRO stock price hit a high of $14.89 and low of $14.74 as of 9 Oct '26.

Can I buy STRO shares in India?

chevron-up
Yes. You can buy STRO in India by opening an international trading account.